Can these 2 FTSE 250 growth stocks justify their valuations?

These FTSE 250 (INDEXFTSE:MCX) stocks are trading at a premium price but is it worth paying? Harvey Jones examines.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Sometimes a heady share price valuation indicates strong growth prospects, although not always. The following two FTSE 250 companies are giving out mixed messages.

Cop that!

Millennium & Copthorne Hotels (LSE: MLC). What a name. It combines a bizarre mixture of the grandiose (Millennium) and the mundane (Copthorne). Actually, that makes sense, given that its Millennium range is aimed at global travellers in gateway cities, while its Copthorne brand offers “comfortable hotels at a comfortable price“. This also gives the company a foot in two slightly different markets.

What it hasn’t done is drive the share price higher. The £1.46bn company’s share price languishes 4% lower than it was five years ago, yet it trades at a pricey 18.65 times earnings. The business has struggled in the US and in particular New York, according to chairman Mr Kwek Leng Beng, who is now looking to overhaul the US management structure in a bid to reverse underperformance.

Lights out

Group revenues are rising elsewhere, notably in London and New Zealand, although Singapore has been hit by uncertain economic conditions, while geo-political tensions have scared tourists away from Seoul and Taipei. Total Q1 revenue rose 2.3% to £218m at constant currency rates but Millennium & Copthorne has been given a helping hand by foreign exchange tailwinds, which drove revenues up 16.1% to £223m in reported currency. Profit before tax slipped a hefty 38.1% to £21m on a constant currency basis, but by a slightly-less-hefty 27.8% to £13m in reported currency.

It seems to me that investors are being offered a Copthorne investment case at a Millennium price, especially when you examine its disappointing 1.7% yield. But wait, City analysts are more optimistic, earnings per share (EPS) are forecast to rise 25% this calendar year, and 4% in 2018, reducing the forward valuation to 15.8 times earnings. However, I still reckon this is one to sleep on for now.

New Page

PageGroup (LSE: PAGE) provides specialist recruitment services in more than 36 countries and operates across a range of specialist industries, including accountancy, engineering, finance, marketing, offshore, oil and gas, retail, sales and technology.

Formerly known as Michael Page International, the group delivered Q1 gross profits of £170.3m, up 9.1% in constant currency and 19.7% in reported rates. This showed a marked improvement on the 3.8% growth in Q4 as underlying trading improved, albeit helped by a one-off lift from Easter being in Q2 this year, against Q1 last year.

New recruit

PageGroup’s share price is up 20% in the last six months which partly justifies its toppy valuation of 20.26 times earnings. You also get a dividend of 2.52%. Its foreign divisions have been outpacing the Brexit-afflicted UK, with profits up 14.8% in Europe, the Middle East and Africa (EMEA), 15.1% in the Americas, and 26% specifically in France. However, Singapore has inflicted some damage here too, as has Brazil and the struggling financial services sector.

PageGroup boasts a strong balance sheet with net cash of £86m and four consecutive years of healthy EPS growth, which should rise another 11% growth this calendar year and 8% in 2018. By then, the yield is expected to have progressed to 3.8%. This stock could be worth recruiting to your portfolio

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »